Company Filing History:
Years Active: 2001-2003
Title: The Innovative Contributions of Jason A. Chesney
Introduction
Jason A. Chesney is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in cancer diagnostics and treatment. With a total of 3 patents to his name, Chesney's work is paving the way for advancements in cancer therapies.
Latest Patents
Chesney's latest patents focus on the role of inducible phosphofructokinase (iPFK-2) and the Warburg effect in cancer malignancy. One of his patents discloses a cancer malignancy diagnostic assay that involves obtaining a sample of body fluid or tissue and performing a sequence identity assay to detect the presence of iPFK-2 specific sequences. Additionally, he has developed an anticancer pharmaceutical composition that includes a specific antisense oligonucleotide targeting the isolated iPFK-2 sequence, along with a pharmaceutically acceptable oligonucleotide carrier. Furthermore, his work includes a method for screening therapeutically active anti-cancer compounds that inhibit iPFK-2, preferably its kinase activity.
Career Highlights
Chesney is affiliated with The Picower Institute for Medical Research, where he conducts his research and develops innovative solutions for cancer treatment. His work is characterized by a commitment to improving diagnostic methods and therapeutic options for cancer patients.
Collaborations
Chesney collaborates with esteemed colleagues in his field, including Richard J. Bucala and Robert A. Mitchell. These partnerships enhance the research efforts and contribute to the development of groundbreaking medical technologies.
Conclusion
Jason A. Chesney's contributions to cancer research through his innovative patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire new approaches in the fight against cancer.